[1] Sánchez-Oro R, Alonso-Muñoz EM, Martí Romero L.  Review of IgG4-related disease[J]. Gastroenterol Hepatol, 2019, 42(10): 638-647.   doi: 10.1016/j.gastrohep.2019.08.009
[2] Mavrogeni S, Markousis-Mavrogenis G, Kolovou G.  IgG4-related cardiovascular disease. The emerging role of cardiovascular imaging[J]. Eur J Radiol, 2017, 86: 169-175.   doi: 10.1016/j.ejrad.2016.11.012
[3] Peng LY, Zhang PP, Li JQ, et al.  IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease[J]. Arthritis Res Ther, 2020, 22(1): 103-.   doi: 10.1186/s13075-020-02197-w
[4] Xiao X, Lian M, Zhang WC, et al.  The immunologic paradoxes of IgG4-related disease[J]. Clin Rev Allergy Immunol, 2018, 54(2): 344-351.   doi: 10.1007/s12016-018-8679-y
[5] Stone JR.  Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease[J]. Curr Opin Rheumatol, 2011, 23(1): 88-94.   doi: 10.1097/BOR.0b013e3283412f7c
[6] Oyama-Manabe N, Yabusaki S, Manabe O, et al.  IgG4-related cardiovascular disease from the aorta to the coronary arteries: multidetector CT and PET/CT[J]. Radiographics, 2018, 38(7): 1934-1948.   doi: 10.1148/rg.2018180049
[7] Pérez-García CN, Olmos C, Vivas D, et al.  IgG4-aortitis among thoracic aortic aneurysms[J]. Heart, 2019, 105(20): 1583-1589.   doi: 10.1136/heartjnl-2018-314499
[8] Zhang JJ, Chen H, Ma YR, et al.  Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study[J]. Eur J Nucl Med Mol Imaging, 2014, 41(8): 1624-1634.   doi: 10.1007/s00259-014-2729-3
[9]

Yabusaki S, Oyama-Manabe N, Manabe O, et al. Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography[J/OL]. EJNMMI Res, 2017, 7(1): 20[2023-03-06]. https://ejnmmires.springeropen.com/articles/10.1186/s13550-017-0268-1. DOI: 10.1186/s13550-017-0268-1.
[10]

Mitamura K, Arai-Okuda H, Yamamoto Y, et al. Disease activity and response to therapy monitored by [18F]FDG PET/CT using volume-based indices in IgG4-related disease[J/OL]. EJNMMI Res, 2020, 10(1): 153[2023-03-06]. https://ejnmmires.springeropen.com/articles/10.1186/s13550-020-00743-w. DOI: 10.1186/s13550-020-00743-w.
[11] Fathala A.  Multimodalities imaging of immunoglobulin 4-related cardiovascular disorders[J]. Curr Cardiol Rev, 2019, 15(3): 224-229.   doi: 10.2174/1573403X15666190117101607
[12] Löffler C, Hoffend J, Rebel M, et al.  A rare cause for lower back pain: a case of an IgG4-related periaortitis[J]. Clin Rheumatol, 2016, 35(1): 265-270.   doi: 10.1007/s10067-014-2535-0
[13] Nikiphorou E, Galloway J, Fragoulis GE.  Overview of IgG4-related aortitis and periaortitis. A decade since their first description[J]. Autoimmun Rev, 2020, 19(12): 102694-.   doi: 10.1016/j.autrev.2020.102694
[14] Perugino CA, Wallace ZS, Meyersohn N, et al.  Large vessel involvement by IgG4-related disease[J]. Medicine (Baltimore), 2016, 95(28): e3344-.   doi: 10.1097/MD.0000000000003344
[15] Ramdin N, Orde M, O'neill SB, et al.  Hidden IgG4-related coronary disease: an autopsy study[J]. Am J Clin Pathol, 2021, 156(3): 471-477.   doi: 10.1093/ajcp/aqaa258
[16] Huang HL, Fong W, Peh WM, et al.  The utility of FDG PET/CT in IgG4-related disease with a focus on coronary artery involvement[J]. Nucl Med Mol Imaging, 2018, 52(1): 53-61.   doi: 10.1007/s13139-017-0494-5
[17] Tsuji S, Iwamoto N, Horai Y, et al.  Comparison of the quantitative measurement of 18F-FDG PET/CT and histopathological findings in IgG4-related disease[J]. Clin Exp Rheumatol, 2021, 39(6): 1338-1344.   doi: 10.55563/clinexprheumatol/bsrhey
[18] Fragoulis GE, Evangelatos G, Tektonidou MG.  Vasculitis beyond aortitis in IgG4-related disease (IgG4-RD): case report and review of the literature[J]. Clin Rheumatol, 2021, 40(3): 1167-1173.   doi: 10.1007/s10067-020-05302-1
[19] Xu X, Bai W, Ma H, et al.  Remission of "mistletoe sign" after treatment[J]. J Cardiovasc Comput Tomogr, 2020, 14(6): e118-e119.   doi: 10.1016/j.jcct.2019.08.002
[20] Russo V, Lovato L, Ligabue G.  Cardiac MRI: technical basis[J]. Radiol Med, 2020, 125(11): 1040-1055.   doi: 10.1007/s11547-020-01282-z
[21] Delgado-García G, Sánchez-Salazar S, Rendón-Ramírez E, et al.  Myocardial ischemia as presenting manifestation of IgG4-related disease: a case-based review[J]. Clin Rheumatol, 2016, 35(11): 2857-2864.   doi: 10.1007/s10067-016-3292-z
[22] Dong AS, Wang Y, Zuo CJ.  FDG PET/CT in IgG4-related peripulmonary arteritis[J]. Clin Nucl Med, 2016, 41(10): e439-e440.   doi: 10.1097/RLU.0000000000001208
[23] Zhou Y, Shao LY, Ruan WJ, et al.  Pulmonary vascular involvement of IgG4-related disease: case series with a PRISMA-compliant systemic review[J]. Medicine (Baltimore), 2019, 98(6): e14437-.   doi: 10.1097/MD.0000000000014437
[24] Deng H, Zhao S, Yue YL, et al.  IgG4-related disease of pulmonary artery causing pulmonary hypertension[J]. Medicine (Baltimore), 2018, 97(20): e10698-.   doi: 10.1097/MD.0000000000010698
[25] Friedberg MK.  Imaging right-left ventricular interactions[J]. JACC Cardiovasc Imaging, 2018, 11(5): 755-771.   doi: 10.1016/j.jcmg.2018.01.028
[26] 薛志伟, 赵倩, 宋丽俊, 等.  经胸超声心动图联合CT对缩窄性心包炎的诊断价值[J]. 中国CT和MRI杂志, 2021, 19(1): 95-97.   doi: 10.3969/j.issn.1672-5131.2021.01.033
Xue ZW, Zhao Q, Song LJ, et al.  Diagnostic value of transthoracic echocardiography combined with CT in constrictive pericarditis[J]. Chin J CT MRI, 2021, 19(1): 95-97.   doi: 10.3969/j.issn.1672-5131.2021.01.033
[27]

Matsuda J, Takano H, Shimizu W. IgG4-related periarteritis in the coronary artery and subclinical pericarditis assessed the presence and monitoring of therapy response by PET and CT scan[J/OL]. BMJ Case Rep, 2018, 2018: bcr2018225172[2023-03-06]. https://casereports.bmj.com/content/2018/bcr-2018-225172.long. DOI: 10.1136/bcr-2018-225172.
[28] Matsumiya R, Hosono O, Yoshikawa N, et al.  Elevated serum IgG4 complicated by pericardial involvement with a patchy 18F-FDG uptake in PET/CT: a typical presentation of IgG4-related disease[J]. Intern Med, 2015, 54(18): 2337-2341.   doi: 10.2169/internalmedicine.54.4340
[29] Manabe O, Yoshinaga K, Ohira H, et al.  The effects of 18-h fasting with low-carbohydrate diet preparation on suppressed physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake and possible minimal effects of unfractionated heparin use in patients with suspected cardiac involvement sarcoidosis[J]. J Nucl Cardiol, 2016, 23(2): 244-252.   doi: 10.1007/s12350-015-0226-0